EN
HI
Summary
As of 14 Nov, 2026, Suven Life Sciences stock price is ₹378.4. During the trading session, the stock has moved between an intraday low of ₹0.00 and an intraday high of ₹0.00. Over the last 52 weeks, Suven Life Sciences has traded between ₹124.11 and ₹403.35.
The stock has recorded a trading volume of 0 shares,. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 100 @ ₹378.40.
Suven Life Sciences has an upper circuit limit of ₹337.95 and a lower circuit limit of ₹225.35. The total value traded stands at ₹0.00, and the delivery percentage for the day is 31.6%.
The stock is currently traded with a market lot size of 1. Suven Life Sciences also offers a dividend yield of 0%.
Suven Life Sciences Share Price Chart
Suven Life Sciences Share Key Metrics
Volume
0.00
Market Cap
10680.87 CR
LTQ@LTP
100@378.40
ATP
0
Var Margin
27.4 %
Circuit Range
225.35-337.95
Delivery %
31.6 %
Value
0.00
ASM/GSM
No
Market Lot
1
Suven Life Sciences Fundamentals
P/E Ratio
0
P/B Ratio
17.32
Div. Yield
0
Sector P/E
41.06
Sector P/B
3.86
Sec. Div. Yield
0.53
Suven Life Sciences Resistance and Support
Pivot 281.17
Resistance
First Resistance
285.49
Second Resistance
289.32
Third Resistance
293.64
Support
First Support
277.34
Second Support
273.02
Third Support
269.19
Suven Life Sciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Nov 13 2026 | 280.35 | 277.8 | -1.36% | 283.45 | 275.1 |
| Thu Nov 12 2026 | 280.14 | 281.64 | 1.35% | 285 | 276.85 |
| Wed Nov 11 2026 | 281.35 | 277.89 | -0.74% | 286.04 | 273.7 |
Suven Life Sciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-05 | Quarterly Results |
| 2026-08-06 | Quarterly Results |
| 2026-05-13 | Audited Results |
| 2026-01-29 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-05-13 | Audited Results & Preferential issue |
| 2025-01-24 | Quarterly Results |
| 2024-10-29 | Quarterly Results |
| 2024-08-05 | Quarterly Results |
Suven Life Sciences News
Suven Life Sciences Ltd - 530239 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven Life Sciences announced it will present seven scientific posters at Neuroscience 2026 in Washington DC from Nov 14-18, 2026. The presentations will highlight clinical and preclinical data for candidates targeting neurodegenerative and neuropsychiatric disorders.
Nov 12 2026 11:44:32
Suven Life Sciences Ltd - 530239 - Board Meeting Intimation for Consideration Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended 30Th September, 2026
Suven Life Sciences board to meet on 5 Nov 2026 for financial results. The meeting will cover the quarter and half-year ended 30 Sep 2026.
Oct 29 2026 15:55:07
Suven Life Sciences Management
| Name | Position |
|---|---|
| Venkateswarlu Jasti | Chairman & Managing Director |
| Seyed E Hasnain | Non Executive Director |
Suven Life Sciences Similar Stocks
Strides Pharma Science Ltd.
1060.00
50.70 (5.02%)
Paras Healthcare Ltd.
0.00
0.00 (0.00%)
Procter & Gamble Health Ltd.
5651.00
-158.00 (2.72%)
Healthcare Global Enterprises Ltd.
703.95
128.20 (22.27%)
Aarti Pharmalabs Ltd.
856.25
-154.25 (15.26%)
Thyrocare Technologies Ltd.
576.40
88.40 (18.11%)
Sanofi India Ltd.
3154.00
-126.90 (3.87%)
Bliss GVS Pharma Ltd.
671.30
29.75 (4.64%)
Kovai Medical Center & Hospital Ltd.
6025.00
-504.50 (7.73%)
FDC Ltd.
342.30
-48.10 (12.32%)
Suven Life Sciences FAQs
The Buying Price of Suven Life Sciences share is 378.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Suven Life Sciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Suven Life Sciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Suven Life Sciences shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Suven Life Sciences shares is 17.32. Useful to assess the stock's value relative to its book value.
To assess Suven Life Sciences’s valuation compare Sector P/E, P/B which are 41.06 & 3.86 with sector averages, along with growth rates and financial metrics.
The Market Cap of Suven Life Sciences is 10680.87 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Suven Life Sciences share price is 403.35 & 124.11. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Suven Life Sciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in SUVEN
